compatibility testing practical blood bank. blood transfusion process  pre-transfusion ...

Download Compatibility Testing Practical Blood Bank. Blood Transfusion Process  Pre-transfusion  Transfusion  Post-transfusion

Post on 24-Dec-2015

234 views

Category:

Documents

3 download

Embed Size (px)

TRANSCRIPT

  • Slide 1
  • Compatibility Testing Practical Blood Bank
  • Slide 2
  • Blood Transfusion Process Pre-transfusion Transfusion Post-transfusion
  • Slide 3
  • What is compatibility testing? Also called pretransfusion testing Purpose: To select blood components that will not cause harm to the recipient and will have acceptable survival when transfused If properly performed, compatibility tests will confirm ABO compatibility between the component and the recipient and will detect the most clinically significant unexpected antibodies
  • Slide 4
  • Compatibility testing? There are several components of compatibility testing Proper specimen collection Reviewing patient transfusion history ABO, Rh, and antibody testing (screen/ID) Crossmatching Actual transfusion
  • Slide 5
  • Compatibility testing Can be divided into 3 categories: Preanalytical procedures Serological testing Postanalytical procedures
  • Slide 6
  • Pre-analytical phases Patient identification Specimen collection Review of patient history
  • Slide 7
  • Patient Identification Must confirm recipients ID from bracelet ON the patient Full patient name and hospital number Name of physician
  • Slide 8
  • Sample Identification The sample should also have the full patient name, hospital number, and physician Date and time of collection, phlebotomists initials All of this should be on the request form and the sample
  • Slide 9
  • Specimen Tubes Pink Top - EDTA Red Top no additives
  • Slide 10
  • Specimen Collection Collected in tube with EDTA or no additives If the venipuncture causes hemolysis, the sample may be rejected True hemolysis in the patient is the result of complement activation Samples are labeled at the bedside (pre-labeling is not recommended) A record of individuals who collect (or test) the specimens should be documented in order to backtrack in case of an error
  • Slide 11
  • Specimen Collection If the sample is drawn from an IV line, the IV infusion should be stopped 5-10 minutes prior to blood drawing and the first 10 mL discarded Testing should be performed on samples less than 72 hours or else complement dependent antibodies may be missed (complement can become unstable)
  • Slide 12
  • Getting the history Look at recipients records for any prior unexpected antibodies Previous transfusion reactions
  • Slide 13
  • Serological Testing 3 tests: ABO/Rh Antibody detection/identification Crossmatch
  • Slide 14
  • ABO/Rh Typing In the ABO typing, the forward and reverse MUST match In the Rh typing, the control must be negative Both of these will indicate what type of blood should be given
  • Slide 15
  • Antibody screen and/or ID The antibody screen will detect the presence of any unexpected antibodies in patient serum If antibodies are detected, identification should be performed using panel cells (with an autocontrol) IS 37 (LISS) AHG If an antibody is present, units negative for the antigen must be given Proceed to the crossmatch
  • Slide 16
  • Crossmatching Purpose: Prevent transfusion reactions Increase in vivo survival of red cells Double checks for ABO errors Another method of detecting antibodies
  • Slide 17
  • Crossmatch Two types of crossmatches Major routinely performed in labs Minor not required by AABB since 1976
  • Slide 18
  • Major vs Minor Crossmatch Why is the minor crossmatch unnecessary? Donated units are tested for antibodies Most blood is transfused as packed cells, having little antibodies The plasma volume is small, and Abs will be diluted in recipient circulation
  • Slide 19
  • Crossmatches The crossmatch shall use methods that demonstrate ABO incompatibility and clinically significant antibodies to red cell antigens and shall include an antiglobulin phase
  • Slide 20
  • Crossmatch Donor RBCs (washed) Patient serum No agglutination ~ compatible Agglutination ~ incompatible
  • Slide 21
  • The procedure Donor cells are taken from segments that are attached to the unit itself Segments are a sampling of the blood and eliminate having to open the actual unit
  • Slide 22
  • Units of whole blood with segments attached
  • Slide 23
  • Procedure ABO/Rh typing is FIRST performed Antibody Screen is performed next.
  • Slide 24
  • Crossmatch Procedure If antibodies are NOT detected: Only immediate spin (IS) is performed using patient serum and donor blood suspension This fulfills the AABB standard for ABO incompatibility This is an INCOMPLETE CROSSMATCH If antibodies ARE detected: Antigen negative units found and X- matched All phases are tested: IS, 37, AHG This is a COMPLETE CROSSMATCH
  • Slide 25
  • Slide 26
  • Crossmatches Will Verify donor cell ABO compatibility Detect most antibodies against donor cells Will Not Garantee normal survival of RBCs Prevent patient from developing an antibody Detect all antibodies Prevent delayed transfusion reactions Detect ABO/Rh errors
  • Slide 27
  • Incompatible crossmatches Antibody screen CrossmatchCauseResolution PositiveNegative Antibody directed against antigen on screening cell ID antibody, select antigen negative blood NegativePositive Antibody directed against antigen on donor cell which may not be on screening cell OR donor unit may have IgG previously attached ID antibody, select antigen negative blood OR perform DAT on donor unit Positive Antibodies directed against both screening and donor cells Antibody ID, select antigen negative blood
  • Slide 28
  • Additional Information on Types of Compatibility Tests Manual (IS and IAT) Gel Technology Electronic (Computerized) Cross match Red cell Affinity Column Technology (ReACT) Solid Phase Adherence Assays (SPAA)
  • Slide 29
  • Manual (IS and IAT) IS detect RT reactive antibodies (Auto, Alloantibody, Naturally occuring) IAT detect IgG antibodies (Auto & alloantibody)
  • Slide 30
  • Gel Technology Patient serum, and 1% of suspended RBCs in LIM are dispensed into the microtube and incubated at 37 o C for 15 minutes. The card containing the microtubes is then centrifuged at a controlled speed for 10 minutes. At the start of centrifugation the cells are separated from the serum; then they meet the AHG contained in the microtube. Finally the cells are trapped by the gel (if agglutinated) or pellet to the bottom of the tube.
  • Slide 31
  • New Technologies The electronic crossmatch According to the AABB, the following must be fulfilled: Critical elements of the information system have been validated on-site. No clinically significant antibodies are detected in the current blood sample and there is no record of clinically significant antibodies in the past
  • Slide 32
  • Computer crossmatch (contd) The patient's ABO group and Rh type has been done twice and entered in the computer The donor ABO/Rh have been confirmed and entered in the computer. The donor unit identification number, component name, and ABO/Rh type must also be entered in the computer The computer system will alert the technologist to ABO & Rh discrepancies between information on the donor label and results of donor confirmatory testing
  • Slide 33
  • Red Cell Affinity Column Technology (ReACT) Based on affinity adherence of coated red cells in an immunologically active matrix. Antibody- sensitized red cells bind or adsorbed to ligands attached to an agarose matrix. The main ligand is Protein G (prepared from Group C or G Streptococcus or by recombinant technology), which has high affinity for all four IgG subclasses. Another ReACT ligand is Protein A (from Group A Staphlococcus), which binds to IgG 1, 2, and 4.
  • Slide 34
  • Red Cell Affinity Column Technology (ReACT) Positive reaction: the coated red blood cells with IgG are bound to immunoreactive gel particles, occurs mostly at the top of the gel column. Negative reaction: the red blood cells are not coated with antibody and pass through to the bottom of the gel column.
  • Slide 35
  • Solid Phase Adherence Assays (SPAA) Uses red cell membrane bound to the surfaces of polystyrene microtitration strip wells, capturing IgG antibodies (if present) in patient sera. Patient serum is added to wells coated with screen cells Incubated at 37 o C for 15 min. Washing anti-IgG-coated indicator red cells are added. centrifuge
  • Slide 36
  • SPAA
  • Slide 37
  • Post-analytical phase Involves labeling, inspecting, and issuing the blood unit Labeling form includes patients full name, ID number, Location, ABO/Rh(D) of patient and unit, donor #, compatibility results, and tech ID Form is attached to the donor unit and only released for the recipient The unit is visually inspected for abnormalities, such as bacterial contamination, clots, etc
  • Slide 38
  • Issuing blood When its time to release a blood product to the nurse or physician, a few checks must be done Requisition form Comparing requisition form donor unit tag blood product label Name of persons issuing and pickin